| Prev Close | 4.24 |
| Open | 4.23 |
| Day Low/High | 4.16 / 4.25 |
| 52 Wk Low/High | 3.36 / 20.80 |
| Volume | 828.36K |
| Avg Volume | 9.05M |
Amarin Corp. Plc (AMRN)
4.18
0.06
1.40
NASDAQ : Health Technology
| Exchange | NASDAQ |
| Shares Outstanding | 385.60M |
| Market Cap | 2.44B |
| EPS | -0.10 |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
3 Small Biotech Stocks With Notable Insider Buying
Several beaten-down small biotech names I own have recently seen insider buying -- an encouraging sign.
Coming This Summer: A Lot Less Travel and a Lot More Market Action
That doesn't mean we'll move straight up over the summer, but we'll get plenty of virus, China, stimulus, cannabis, and unemployment chatter.
Keeping Sane, the Profitable Way: How I'm Playing This Market
I continue to shuttle new money into the market on declines using buy-write option strategies.
4 Biotech Stocks I'm Targeting Now
I've stayed primarily to those names that have plenty of cash on the balance sheet and should be just fine once saner heads prevail.
The Charts of Amarin Tell Us That a Close Below $14 Is Key
Let's check the charts of this bio pharmaceutical company that develops drugs for cardiovascular disease.
Amarin Stock's Outlook Not for the Faint of Heart
Buyers will need patience and tolerance for risk as AMRN is likely to continue to trade sideways and could decline, according to the charts and indicators.
Bullish Looking Amarin Is Set to More Than Double From Current Levels
Pharmaceutical firm AMRN developments therapeutics for the treatment of cardiovascular diseases.
Focus on the Trees, Not the Forest
The current market favors stock pickers.
Big Merger Monday Conjures Up Thoughts of Potential Biotech Targets
The planned acquisition of The Medicines Company by Novartis spurs prospects of other deals in the drug business.
New Doubts About a U.S./China Trade Deal Pushed Markets Off the Ledge
For many market players, corrective action at this point is a positive rather than a negative.
Why Stock Charts Are a More Valuable Tool Than Ever
What I have found is that the real value of charts is as a trade management tool.
This Is a Short Term Trading Market
This is not the time to make a big directional call.
An Interesting Small-Cap on My Radar This Morning Is Coda Octopus
I added shares this morning and will be looking for more entry points as it develops.
Stocks Take Flight on Dovish Fed Comments
Market players are trying to decipher Fed Chair Powell's latest words.
I Have My Eye on This Warren Buffett Stock Amid the Choppy Action
Market players are more skeptical of the quick moves on U.S.-China trade news.
Lyft's Aggressive IPO Pricing Was a Mistake
Poor trading action in Lyft will likely create some distrust of upcoming IPOs, and Uber in particular.
The Best Approach to Trading Lyft
Valuation and all the other issues that are being discussed are secondary to the price action.
Market Gains Some Momentum, Lululemon Breaks Out
While there is some positive movement, it has not been sustained which makes trading quite tricky.
The Market Worries About Global Growth but Looks for Progress on China Trade
China negotiations resume today and the potential for weekend news is high.
What Will Warren Buffett Say About Kraft Heinz?
So far there is no bounce in Kraft Heinz which is not a good sign.
Trading Notes for Select Stocks
Here's my take on a list of stocks I've been watching.
Facebook Is Today's Star as Pockets of Strong Momentum Grow
It is the action in secondary stocks that is giving the action a much better feel.
This Market May Just Be in an Uptrend: Market Recon
This is the kind of reversal that happens in a bull market.
CAT Stock Gets Thrown Into the Dumpster
This stock can become much cheaper if there is a major cycle turn occurring.
There Are No Safe Havens Right Now
The indices need to find support and we need some better pockets of strength.
Play Amarin's 'Home-Run Potential'
Latest trial results appear to show the biotech has a super fish oil pill with potential to aid those with high triglycerides.
Amarin Continues to Impress
The market continues to be flat as we enter the last hour of the trading week. It looks like the SCOTUS nomination fight will drag out for at least another divisive week as a couple of Republican senators cave in supporting another FBI investigatio...
